(Q57601914)

English

A single-center, randomized, double-blind, placebo-controlled study of interferon beta-1b on primary progressive and transitional multiple sclerosis

scientific article published on 29 September 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19797261%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

A single-center, randomized, double-blind, placebo-controlled study of interferon beta-1b on primary progressive and transitional multiple sclerosis (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19797261%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

multiple sclerosis

0 references

1 reference

based on heuristic

inferred from title

Xavier Montalban

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19797261%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Jaume Sastre Garriga

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19797261%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19797261%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19797261%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

author name string

L Brieva

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19797261%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

F X Aymerich

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19797261%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

J Porcel

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19797261%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

C Borràs

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19797261%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

C Nos

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19797261%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

A Rovira

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19797261%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

publication date

29 September 2009

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19797261%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Multiple Sclerosis Journal

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19797261%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

15

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19797261%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19797261%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

1195-1205

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19797261%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial. UBC MS/MRI Study Group and the IFNB Multiple Sclerosis Study Group

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106937

21 January 2018

Effect of early versus delayed interferon beta-1b treatment on disability after a first clinical event suggestive of multiple sclerosis: a 3-year follow-up analysis of the BENEFIT study

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106937

21 January 2018

Benefit of interferon beta-1a on MSFC progression in secondary progressive MS.

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106937

21 January 2018

Interferon beta-1b in secondary progressive MS: results from a 3-year controlled study.

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106937

21 January 2018

Interferon beta-1a in primary progressive MS: an exploratory, randomized, controlled trial.

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106937

21 January 2018

Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: results of a phase III multicenter, double-blind placebo-controlled trial. The Copolymer 1 Multiple Sclerosis Study Group

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106937

21 January 2018

Glatiramer acetate in primary progressive multiple sclerosis: results of a multinational, multicenter, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106937

21 January 2018

Inflammatory demyelination is not central to the pathogenesis of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106937

21 January 2018

Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106937

21 January 2018

Cortical demyelination and diffuse white matter injury in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106937

21 January 2018

Immunologic factors in primary progressive multiple sclerosis

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106937

21 January 2018

Primary-progressive multiple sclerosis

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106937

21 January 2018

Progress in deciphering the genetics of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106937

21 January 2018

Is inflammation important in early PPMS? a longitudinal MRI study.

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106937

21 January 2018

PROBLEMS OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS: REPORT BY THE PANEL ON THE EVALUATION OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106937

21 January 2018

Primary and transitional progressive MS: a clinical and MRI cross-sectional study

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106937

21 January 2018

Low-dose steroids reduce flu-like symptoms at the initiation of IFNbeta-1b in relapsing-remitting MS.

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106937

21 January 2018

An Inventory for Measuring Depression

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106937

21 January 2018

The Brief Repeatable Battery of Neuropsychological Tests for Multiple Sclerosis: a preliminary serial study.

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106937

21 January 2018

Visual analysis of serial T2-weighted MRI in multiple sclerosis: intra- and interobserver reproducibility

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106937

21 January 2018

Defining the clinical course of multiple sclerosis: Results of an international survey

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106937

21 January 2018

Primary progressive multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106937

21 January 2018

Transitional progressive multiple sclerosis: a clinical and imaging study.

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106937

21 January 2018

The effect of interferon beta-1a on spasticity in primary progressive multiple sclerosis

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106937

21 January 2018

Long-term clinical outcome of primary progressive MS: predictive value of clinical and MRI data

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106937

21 January 2018

The effect of interferon beta-1b treatment on MRI measures of cerebral atrophy in secondary progressive multiple sclerosis. European Study Group on Interferon beta-1b in secondary progressive multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106937

21 January 2018

Transitional progressive multiple sclerosis: MRI and MTI findings

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106937

21 January 2018

Primary progressive multiple sclerosis

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106937

21 January 2018

The natural history of multiple sclerosis: a geographically based study 9: Observations on the progressive phase of the disease

1 reference

https://api.crossref.org/works/10.1177%2F1352458509106937

21 January 2018

Identifiers

10.1177/1352458509106937

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19797261%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19797261%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q57601914&oldid=2172013499"